Publicaciones en las que colabora con Maria del Pilar Oviedo Cáceres (17)

2011

  1. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway

    Molecular and Cellular Endocrinology, Vol. 335, Núm. 2, pp. 96-103

  2. Progestogens reduce thromboxane production by cultured human endothelial cells

    Climacteric, Vol. 14, Núm. 1, pp. 41-48

2010

  1. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-α

    Journal of Molecular Endocrinology, Vol. 44, Núm. 4, pp. 237-246

2009

  1. Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells

    PLoS ONE, Vol. 4, Núm. 12

2008

  1. Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?

    European Journal of Obstetrics and Gynecology and Reproductive Biology

  2. Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women

    Gynecological Endocrinology, Vol. 24, Núm. 6, pp. 354-357

  3. Transdermal estradiol reduces F2α-isoprostane levels in postmenopausal women

    Menopause, Vol. 15, Núm. 4, pp. 714-717

2007

  1. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells

    Cardiovascular Research, Vol. 73, Núm. 1, pp. 66-72

  2. Raloxifene**Lilly Research Laboratories, Indianapolis, Indiana. increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1

    Fertility and Sterility, Vol. 88, Núm. 2, pp. 326-332

  3. Selective estrogen receptor modulators and risk for coronary heart disease

    Climacteric, Vol. 10, Núm. 2, pp. 97-111

  4. The risk for cardiovascular disease in women: From estrogens to selective estrogen receptor modulators

    Frontiers in Bioscience, Vol. 12, Núm. 1, pp. 49-68

2006

  1. Cyclooxygenases regulation by estradiol on endothelium

    Current Pharmaceutical Design, Vol. 12, Núm. 2, pp. 205-215

2005

  1. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 315, Núm. 2, pp. 722-728

  2. Progestogens stimulate prostacyclin production by human endothelial cells

    Human Reproduction, Vol. 20, Núm. 6, pp. 1554-1561

  3. Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and -2

    Fertility and Sterility, Vol. 83, Núm. 6, pp. 1822-1829

  4. Therapeutic dosages of raloxifene do not modify myeloperoxidase and F 2α-isoprostane levels in postmenopausal women

    Fertility and Sterility, Vol. 84, Núm. 6, pp. 1789-1792

2004

  1. Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: Implication of COX-1 and COX-2

    Menopause, Vol. 11, Núm. 4, pp. 430-437